|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Influenza Virus A IgG ELISA | Anti-Ustekinumab (Stelara®) ELISA | Chromogranin A IRMA Assay | Echinococcus IgG ELISA | Tenascin-C High Molecular Weight Variants ELISA Assay |
| Citations | | | | | |
| Catalog Number | IB79878 | TM09036 | RB321RUO | IB79843 | 27751 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | The Influenza Virus A IgG ELISA is intended for the qualitative determination of IgG class antibodies against Influenza Virus A in human serum or plasma (citrate, heparin). FDA exempt, can be used for in-vitro diagnostics. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | Radioimmunoassay (RIA) for the determination of chromogranin A (CGA) in human serum or plasma. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay for the determination of IgG class antibodies against Echinococcus in human serum or plasma. 510(k) exempt, can be used for in-vitro diagnostics. | Solid phase sandwich ELISA for the determination of Human Tenascin-C containing high molecular weight variants (Human Tenascin-C HMWV) in serum, plasma (heparin), or cell culture media. For research use only, not for use in diagnostic procedures. |
| Detection Target | Sex Hormone Binding Globulin (SHBG) | sAPP Total | sAPPß-sw | Pregnenolone | CA 242 |
| Sample Type | Human Serum | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Blood Plasma of the Tg2576 transgenic mouse, Cell Culture Supernatent | Serum | Serum |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Radio Immuno Assay (RIA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A cut-off control is used for the interpretation of results. | Anti-Ustekinumab (Stelara®) | Chromogranin A | A cut-off control is used for the interpretation of results. | 0.38 to 24 ng/mL |
| Sensitivity | 0.1 nmol/L | 0.06 ng/mL | 0.07 ng/mL | 0.05 ng/mL | Inquire |
| Assay Time | 1 hr 45 mins (incubation) | 2 hour, 30 min. total incubation time. | 20 to 24 hrs 45 mins (incubation) | 1 hour, 45 min. total incubation time. | 2 hrs (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |